Oridonin at concentrations of 28–56 μmol·L−1 inhibits human lung cancer cell line SPC‐A1 (SPC‐A1) cell growth; promotes cell apoptosis via downregulation of Bcl‐2 and upregulation of Bax proteins. Here, BAX is linked to lung carcinoma.